Skip to content

Beer after wine versus wine after beer

Beer after wine versus wine after beer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015285
Enrollment
120
Registered
2018-08-22
Start date
2017-07-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol induced hangover

Interventions

Group 1: On study day one, study group 1 consumes beer up to a breath alcohol concentration (BrAC) of =0.05% and subsequently wine to a BrAC of 0.11%. On study day two (crossover), the wine and beer c

Sponsors

Witten/Herdecke University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Male and female participants, Age: 18 to 60 years, Provided written informed consent (see attachment: consent form), Positive matched-triplet result, Positive history of beer and wine consumption

Exclusion criteria

Exclusion criteria: o Age: < 18 years o Limited legal competence/ability to make legal judgement o Chronic alcohol abuse or drug abuse o Aversion to beer or wine (or both) o Complete alcohol abstinence or intolerance o Diseases/conditions that - influence the metabolism of alcohol - may affect the trial outcome as well as - constitute a contraindication for alcohol consumption ? Alcoholic liver disease ? Viral hepatitis ? Hepatocellular carcinoma ? Chronic pain ? Diabetes mellitus type 2 ? Epilepsy ? Wernicke encephalopathy, thiamine deficiency ? Korsakov syndrome ? Gastritis, bariatric surgery ? Immunosuppression ? Recent history of infection (i.e. respirator, etc.) o Pregnancy of breastfeeding o Eastern Asian ethnicity - due to prevalence of congenital intolerance to alcohol o Use of medications known to interact with alcohol - via cytochrome 2E1 ? Paracetamol, Barbiturate, Isoniazid, ? Cyclophosphamide, Halothane, ? Methadone, Phenylbutazone, Propranolol ? Rifampicin, Warfarin, Tolbutamide ? Traquilizer, Vitamin A - via ADH ? Cimetidine, Ranitidine, Chlorpromazine ? Chloral hydrate - via ALDH ? Sulphonylurea, Sulfonamide, ? Metronidazole, Griseofulvin, Tolazoline ? Procarbazine, antimalarial agents ? Chloramphenicol - as well as ? Antidiabetics, Antibiotics, Opioids, Nitrates

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the reported hangover severity on the day following each intervention. Hangover intensity is scored by acute hangover scale (AHS, Rohsenow et al. 2007) – an eight-item compound score (including thirst, fatigue, headache, dizziness, nausea, stomach ache, tachycardia and loss of appetite). Each item is rated between 0 and 7 by the study subject on the day following the intervention, once BrAC has returned to zero. A score of 56 corresponds to the worst imaginable hangover, 0 represents the absence of hangover symptoms. Study groups 1 and 2 and the control group will be compared regarding AHS values on the day following each intervention.

Secondary

MeasureTime frame
The secondary endpoints are factors associated with hangover intensity (e.g. demographics, laboratory parameters, self-assessment of perceived drunkenness, etc.).

Countries

Germany

Contacts

Public ContactKai Hensel

Universität Witten/Herdecke

kai.hensel@uni-wh.de00492028963831

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026